ANDA 78048, held by Kvk Tech. Cyclobenzaprine Hydrochloride.
As of Nov 16, 2026, ANDA 78048 (Cyclobenzaprine Hydrochloride), held by Kvk Tech, was first approved by FDA on Feb 28, 2011, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 28, 2011 | Original application | Approved | None posted |
| Cyclobenzaprine Hydrochloride5MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Cyclobenzaprine Hydrochloride10MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Apr 11, 2013 | Supplement 2Labeling · Standard review | Approved | None posted |
| Feb 28, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters